IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Nureca IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 100.00 Cr. The company is based in Mumbai and caters to Healthcare - Personal Care sector. Iti Capital is the merchant banker of Nureca IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 10th November 2020.
Nureca IPO posted revenues of ₹ 245.94 crores and PAT of ₹ 72.36 crores in FY21 on annualised basis.
Revenue:
₹ 24.20 Cr.
EBITDA Margin:
412.23
% 
Net Worth: ₹ 51.60 Cr.
Market Capitalisation:
[●]
P/E:
5.53 times
P/BV: [●]
EV/EBITDA: -0.02 times
Financial results of Nureca IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-20 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 102.48 | 33.80 | 23.50 | 7.01 | |
| Net Worth | 51.60 | 14.90 | 7.90 | 1.70 | |
| Total Debt | 9.20 | 9.37 | 0.26 | [●] | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
12.10
24.20 |
99.40 | 61.80 | 20.05 | |
EBITDA
EBITDA on annualised basis |
49.88
99.76 |
9.74 | 9.14 | 4.39 | |
PAT
PAT on annualised basis |
36.18
72.36 |
6.39 | 6.22 | 3.11 | |
Nureca IPO PAT Margin is 299.01 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Nureca IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-20 | FY20 | FY19 | FY18 |
|---|---|---|---|---|
| EBITDA Margin (%) | 412.23 | 9.80 | 14.79 | 21.90 |
| PAT Margin (%) | 299.01 | 6.43 | 10.06 | 15.51 |
| EPS (₹) | 51.69 | 9.14 | 8.89 | 4.45 |
| ROE (%) | 70.12 | 42.89 | 78.73 | 182.94 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 35.30 | 18.91 | 26.47 | 44.37 |
| Debt to Equity | 0.18 | 0.63 | 0.03 | [●] |
The market Capitalisation of Nureca IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Nureca IPO prospectus highlights an Return on Equity (ROE) of 70.12 % , Return on Assets (ROA) of 35.30 %, and an EBITDA Margin of 412.23 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Nureca IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Nureca IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Nureca IPO has a Price-to-Earnings (PE) ratio of 5.53 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Nureca IPO reported revenue of ₹ 245.94 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Nureca IPO provide insights into sales growth, market demand, and business scalability.
Nureca recorded an EBITDA of ₹ 99.76 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Nureca Profit After Tax (PAT) is ₹ 72.36 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 24.20 Cr.
EBITDA Margin:
412.23
%
Net Worth: ₹ 51.60 Cr.
Market Capitalisation:
[●]
P/E:
5.53 times
P/BV: [●]
EV/EBITDA: -0.02 times
Nureca operates in Healthcare - Personal Care and Business Of Home Healthcare And Wellness Products. The Issue is listed on BSE,NSE in Feb, 2021. Nureca IPO size was 100.00 with Issue price of 400.00 .
Merchant Banker(s) of Nureca IPO: Iti Capital Limited
Nureca IPO subscription was 39.93 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Nureca IPO listed at a listing price of 666.65 against the offer price of 400.00.
The current market price of Nureca is 286.60.
Why Us?
